MARKET

SER

SER

Serina Therapeutics
AMEX
1.913
-0.098
-4.87%
After Hours: 1.913 0 0.00% 16:10 12/31 EST
OPEN
1.950
PREV CLOSE
2.011
HIGH
2.060
LOW
1.710
VOLUME
46.40K
TURNOVER
--
52 WEEK HIGH
7.92
52 WEEK LOW
1.710
MARKET CAP
20.40M
P/E (TTM)
-1.0165
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SER last week (1222-1226)?
Weekly Report · 12/29/2025 09:30
Top Serina Therapeutics Insider Makes a Sudden Move With Company Stock
TipRanks · 12/24/2025 02:01
Weekly Report: what happened at SER last week (1215-1219)?
Weekly Report · 12/22/2025 09:29
Weekly Report: what happened at SER last week (1208-1212)?
Weekly Report · 12/15/2025 09:32
Insider Moves: Serina Therapeutics Executive Sells Shares!
TipRanks · 12/13/2025 02:10
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Barchart · 12/11/2025 15:15
Serina Therapeutics Submits Complete Response To FDA Clinical Hold Letter For SER-252, Lead Program For Advanced Parkinson's Disease
Benzinga · 12/10/2025 21:34
Weekly Report: what happened at SER last week (1201-1205)?
Weekly Report · 12/08/2025 09:32
More
About SER
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.